{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T05:25:22Z","timestamp":1787376322227,"version":"build-2736575974"},"reference-count":16,"publisher":"Editorial Committee of Annals of Thoracic and Cardiovascular Surgery","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ATCS","Ann Thorac Cardiovasc Surg"],"published-print":{"date-parts":[[2026]]},"DOI":"10.5761\/atcs.oa.26-00068","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T22:10:52Z","timestamp":1787350252000},"page":"n\/a","source":"Crossref","is-referenced-by-count":0,"title":["Skip N2 Metastasis in Resected Lung Cancer: Prognostic Subclassification by Lymphatic Drainage and Histology"],"prefix":"10.5761","volume":"32","author":[{"given":"Shixiong","family":"Yao","sequence":"first","affiliation":[{"name":"Department of Cardiothoracic Surgery, Xiaogan First People\u2019s Hospital Thoracic Surgery, Xiaogan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Xiaogan First People\u2019s Hospital Thoracic Surgery, Xiaogan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaobin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, Xiaogan First People\u2019s Hospital Thoracic Surgery, Xiaogan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3757","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Goldstraw P, Crowley J, Chansky K, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007; 2: 706\u201314.","DOI":"10.1097\/JTO.0b013e31812f3c1a"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Chansky K, Detterbeck FC, Nicholson AG, et al. The IASLC Lung Cancer Staging Project: external validation of the revision of the TNM stage groupings in the eighth edition of the TNM Classification of lung cancer. J Thorac Oncol 2017; 12: 1109\u20131121.","DOI":"10.1016\/j.jtho.2017.04.011"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Waqar S. The 8th edition of the TNM Classification for lung cancer. Oncol Times 2015; 37: 6\u20138.","DOI":"10.1097\/01.COT.0000473096.46917.cf"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Wang Z, Cheng J, Huang W, et al. Skip metastasis in mediastinal lymph node is a favorable prognostic factor in N2 lung cancer patients: a meta-analysis. Ann Transl Med 2021; 9: 218.","DOI":"10.21037\/atm-20-3513"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Liang S, Yang Y, Tian J, et al. Prognostic impacts of skip metastasis in N2a and N2b subgroups of non-small cell lung cancer: insights from a large cohort. Transl Lung Cancer Res 2025; 14: 2537\u201359.","DOI":"10.21037\/tlcr-2025-272"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Seyrek Y, Cansever L, Ak\u0131n H, et al. The significance of skip mediastinal lymph node metastasis in the prognosis of patients with resected non-small-cell lung carcinoma: is it really a better N2 disease subtype? Ann Thorac Cardiovasc Surg 2021; 27: 304\u201310.","DOI":"10.5761\/atcs.oa.20-00289"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Tanaka F, Takenaka K, Oyanagi H, et al. Skip mediastinal nodal metastases in non-small cell lung cancer. Eur J Cardiothorac Surg 2004; 25: 1114\u201320.","DOI":"10.1016\/j.ejcts.2004.03.001"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Prenzel KL, Baldus SE, M\u00f6nig SP, et al. Skip metastasis in nonsmall cell lung carcinoma: predictive markers and isolated tumor cells in N1 lymph nodes. Cancer 2004; 100: 1909\u201317.","DOI":"10.1002\/cncr.20165"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Nicholson AG, Tsao MS, Beasley MB, et al. The 2021 WHO classification of lung tumors: impact of advances since 2015. J Thorac Oncol 2022; 17: 362\u201387.","DOI":"10.1016\/j.jtho.2021.11.003"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Citak N, Sayar A, Metin M, et al. The prognostic significance of metastasis to lymph nodes in aortopulmonary zone (stations 5 and 6) in completely resected left upper lobe tumors. Thorac Cardiovasc Surg 2015; 63: 568\u201376.","DOI":"10.1055\/s-0035-1546463"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Lin B. Narrative review of patterns of lymphatic drainage in early-stage non-small cell lung cancer. Ame Med J. 2021; 6: 41.","DOI":"10.21037\/amj-20-172"},{"key":"12","unstructured":"12) Neef H. Anatomical pathways of lymphatic flow between lung and mediastinum. Ann Ital Chir 1999; 70: 857\u201366."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Wang X, Guo H, Hu Q, et al. The impact of skip vs. non-skip N2 lymph node metastasis on the prognosis of non-small-cell lung cancer: a systematic review and meta-analysis. Front Surg 2021; 8: 749156.","DOI":"10.3389\/fsurg.2021.749156"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Tsitsias T, Okiror L, Veres L, et al. New N1\/N2 classification and lobe specific lymphatic drainage: Impact on survival in patients with non-small cell lung cancer treated with surgery. Lung Cancer 2021; 151: 84\u201390.","DOI":"10.1016\/j.lungcan.2020.11.005"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Felip E, Altorki N, Zhou C, et al. Overall survival with adjuvant atezolizumab after chemotherapy in resected stage II-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase III trial. Ann Oncol 2023; 34: 907\u201319.","DOI":"10.1016\/j.annonc.2023.07.001"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) O\u2019Brien M, Paz-Ares L, Marreaud S, et al. Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB-IIIA non-small-cell lung cancer (PEARLS\/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial. Lancet Oncol 2022; 23: 1274\u201386.","DOI":"10.1016\/S1470-2045(22)00518-6"}],"container-title":["Annals of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/atcs\/32\/1\/32_oa.26-00068\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T04:39:24Z","timestamp":1787373564000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/atcs\/32\/1\/32_oa.26-00068\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5761\/atcs.oa.26-00068","relation":{},"ISSN":["1341-1098","2186-1005"],"issn-type":[{"value":"1341-1098","type":"print"},{"value":"2186-1005","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"oa.26-00068"}}